These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6456074)

  • 1. Heterogeneity of tolerance to xenogenic cells in mice inoculated at birth with rat cells.
    Chutná J; Holán V; Hasek M
    Cell Immunol; 1981 Sep; 63(1):193-7. PubMed ID: 6456074
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
    Hirsch MS
    Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
    [No Abstract]   [Full Text] [Related]  

  • 4. A unique mechanism of tolerance by perioperative intrathymic injection of bone marrow cells with a short course of ALS and FK506 in the rat cardiac allograft model.
    Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H
    Transplant Proc; 1997; 29(1-2):1137-8. PubMed ID: 9123237
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 6. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful induction of specific hyporeactivity to rat skin xenografts in newborn mice. Effect of immunoregulatory molecules.
    Holán V
    Transplantation; 1987 Dec; 44(6):809-12. PubMed ID: 2962344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of activated specific suppressor T cells in maintenance of transplantation tolerance.
    Hilgert I
    Immunol Rev; 1979; 46():27-53. PubMed ID: 157972
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML; Gozzo JJ; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial tolerance and immunity after adoptive abrogation of transplantation tolerance in the rat.
    Elkins WL; Adams JS; Fox DH; Wilson DB; Stuart FP
    Cell Immunol; 1973 Dec; 9(3):412-25. PubMed ID: 4148477
    [No Abstract]   [Full Text] [Related]  

  • 12. The significance of the variety of mechanisms of allograft tolerance.
    McCullagh P
    Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():1-10. PubMed ID: 3516128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-tolerance restoration of irradiated graft-versus-host mice after thymus grafting.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1995 Aug; 27(4):2486-7. PubMed ID: 7652898
    [No Abstract]   [Full Text] [Related]  

  • 15. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 16. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with procarbazine, antilymphocyte serum, and donor-type cells.
    Floersheim GL
    Transplantation; 1973 Feb; 15(2):195-205. PubMed ID: 4146168
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
    Gozzo JJ; Kowolenko M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergy between injection of F1 spleen cells and thymectomy on maintenance of skin allograft tolerance in adult recipient mice treated with supralethal irradiation followed by syngeneic bone marrow cell transplantation.
    Tomita Y; Mayumi H; Nomoto K
    Transplant Proc; 1990 Feb; 22(1):251-6. PubMed ID: 2137950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.